1,3-Propanediol (1,3-PDO) is an important compound that is mainly used 21 in industry for polymer production. Fermentation of 1,3-PDO from glycerol by marine 22 Klebsiella pneumoniae is accompanied by formation of 2,3-butanediol (2,3-BDO) as 23 one of the main byproduct. The first step in the formation of 2,3-BDO from pyruvate 24 is catalyzed by acetolactate synthase (ALS), an enzyme that competes with 1,3-PDO 25 oxidoreductase for the cofactor NADH. This study aimed to analyze the impact of 26 engineering the 2,3-BDO formation pathway via inactivation of ALS on 1,3-PDO 27 fermentation by marine K. pneumoniae HSL4. An ALS mutant was generated using 28 Red recombinase assisted gene replacement. The ALS specific activities of K. 29 pneumoniae ΔALS were notably lower than that of the wild-type strain. Fed-batch 30 fermentation of the mutant strain resulted in a 1,3-PDO concentration, productivity 31 and conversion of 72.04 g L -1 , 2.25 g L -1 h -1 , and 0.41 g g -1 , a slightly increase 32 compared with the parent strain. Moreover, inactivation of ALS decreased 33 meso-2,3-BDO formation to trace amounts, significantly increased 2S,3S-BDO and 34 lactate production, and a pronounced redistribution of intracellular metabolic flux was 35 apparent. 36 37
microorganisms produce 1,3-PDO including Klebsiella pneumoniae, Citrobacter 48 freundii, Clostridium butyricum, and Clostridium acetobutylicum [5] [6] [7] . Of these, K. 49 pneumoniae has been most widely explored since it achieves a higher concentration of 50 1,3-PDO, greater productivity, and a higher rate of conversion using glycerol as the 51 carbon source [8, 9] . 52 In K. pneumoniae metabolism, glycerol is dissimilated through coupled reductive 53 and oxidative pathways (Fig. 1) . 1,3-PDO is synthesized in the reductive pathway, 54 whereas in the oxidative pathway, pyruvate-derived by-products such as 55 2,3-butanediol (2,3-BDO), acetate (AC), lactate (LAC), succinate (SUC) and ethanol 56 (ETH) are generated through the channeling of glycerol into glycolysis [10] . 57 Generation of by-products can compete with the biosynthesis of 1,3-PDO for carbon 58 flow and NADH, which can lower the yield of 1,3-PDO. Blocking both the ETH and 59 LAC pathways can reduce the production of by-products and can increase 1,3-PDO 60 [11] [12] [13] . 61 2,3-BDO is the main byproduct generated alongside 1,3-PDO in the oxidative 4 62 catabolism of glycerol, and both compounds share a similar high boiling point and 63 water solubility. Therefore, 2,3-BDO not only competes for carbon flow, but also 64 complicates 1,3-PDO recovery and purification [14] . Minimizing 2,3-BDO production 65 would therefore improve the yield of 1,3-PDO and simplify the downstream 66 processing [15, 16] . 67 2,3-BDO is a metabolite derived from pyruvate (Fig. 1 ). In the 68 Enterobacteriaceae family, pyruvate from glycolysis can be converted into either 69 LAC in an NADH-dependent reaction catalyzed by L-/D-LAC dehydrogenase (LDH) 70 or, after decarboxylation, into acetolactate in a reaction catalyzed by acetolactate 71 synthase (ALS), encoded by the budB gene. Acetolactate is mostly produced when 72 NADH availability is low, and under aerobic conditions, it can be converted to acetoin 73 by acetolactate decarboxylase (ALD), encoded by the budA gene. If oxygen is present, 74 acetolactate can undergo spontaneous decarboxylation to produce diacetyl, and 75 diacetyl reductase (DAR; also known as acetoin dehydrogenase) converts diacetyl to 76 acetoin. Finally, butanediol dehydrogenase (BDH), encoded by the budC gene, also 77 known as acetoin reductase, reduces acetoin to 2,3-BDO [17] . 78 In this study, a 2,3-BDO pathway-deficient mutant of K. pneumoniae was 79 constructed by knocking out the budB gene to generate a variant strain lacking ALS. 80 The physiological and fermentation properties of the mutant strain, including the 81 distribution and yield of various metabolites and products, were subsequently 82 investigated. In particular, the influence that blocking the 2,3-BDO pathway has on 83 glycerol metabolism and 1,3-PDO production was studied. The ALS mutant strain K. pneumoniae ΔALS was constructed following a method The ALS assay was based on enzymatic conversion of pyruvate to acetoin through 135 acetolactate, and was conducted as described by Yang et al. [23] . Samples were 136 collected and centrifuged at 5000 × g, 4C for 10 min, supernatants were removed, 137 and pellets were stored at 4C until needed for analysis. Pellets were washed with 138 cold 50 mM acetate buffer pH 6, centrifuged at 5000 × g, 4C for 10 min, 139 resuspended in the same buffer at 4C, and crude cell extracts (for use in enzyme 140 assays) were obtained by sonication with an ultrasonic cell disrupter. Reaction 141 mixtures contained 20 mM sodium pyruvate, 50 mM acetate buffer pH 6, 1 mM 142 MgCl 2 , and 80 mL of cocarboxylase. Reactions were initiated by the addition of 100 143 μL of crude extract to 1 mL of reaction buffer and followed for 20 min at 37C. 144 Reactions were terminated by addition of 0.1 mL of 50% H 2 SO 4 . Mixtures were 145 incubated for an additional 25 min at 37C to allow acid hydrolysis of acetolactate to 146 acetoin, and acetoin was measured using the Voges-Proskauer test. Briefly, a 0.2 mL 147 aliquot of the aforementioned mixture was transferred to a tube with 0.8 mL of 0.45 148 M NaOH, and 1 mL of α-naphthol (5% in 2.5 M NaOH) and 0.5% creatine (1:1) was 149 added. Reactions were incubated at room temperature for 30 min with slightly shaking, 8 150 and the absorbance at 535 nm was measured. Calibration with pure acetoin showed a 151 correlation of 1 OD 535 unit to 0.15 mM acetoin. One specific unit of ALS activity 152 corresponds to the formation of 1 mmol of acetoin per mg of protein per minute. 153 154 2.5 Biomass and fermentation broth analysis 155 Cell density was monitored using a spectrophotometer at 600 nm (OD 600nm ). 156 Glycerol, 1,3-PDO, 2,3-BDO, LAC, SUC, AC and ETH were determined using a 157 Shimadzu 20AT HPLC system equipped with a 300 × 7.8mm 2 Aminex HPX-87H 158 column (Bio-Rad, USA) running at 0.8 ml min -1 after adding 5 mM H 2 SO 4 . The effect of ALS inactivation on cell growth was examined during fermentation 169 (Fig. 3A) . The maximum OD 600nm (biomass) reached was 6.80, and the growth of K. 170 pneumoniae ΔALS was unaffected compared with the wild-type strain. Consumption 171 of glycerol by K. pneumoniae ΔALS and K. pneumoniae HSL4 were also monitored 9 172 in a fed-batch culture, and the glycerol consumption rate (5.50 g L -1 h -1 ) of K. 173 pneumoniae ΔALS was slightly higher than that of K. pneumoniae HSL4 (5.34 g L -1 174 h -1 ), as shown in Fig. 3B . These results indicated that the consumption of glycerol 175 was slightly promoted by inactivation of ALS, and further investigation revealed a 176 notably lower ALS specific activity in the crude cell extract of K. pneumoniae ΔALS 177 than the wild-type strain (Fig. 3C ). including 31.50 g L -1 LAC, 8.30 g L -1 SUC, 9.60 g L -1 AC, 7.60 g L -1 ETH, and 2.16 191 g L -1 2,3-BDO. In comparison, K. pneumoniae HSL4 produced 15.42 g L -1 LAC, 7.76 192 g L -1 SUC, 7.02 g L -1 AC, 9.23 g L -1 ETH, and 13.75 g L -1 2,3-BDO. 193 As shown in Table 2 , glycerol consumption by K. pneumoniae ΔALS was slightly 10 194 higher than that of the parent strain. 1,3-PDO reached a final concentration of 72.04 g 195 L -1 in K. pneumoniae ΔALS, which was an slightly increase of 4.71% compared to 196 the parent strain. Similarly, 1,3-PDO productivity was 2.25 g L -1 h -1 with K. 197 pneumoniae ΔALS, higher than K. pneumoniae HSL4 (2.15 g L -1 h -1 ). However, there 198 was no notable difference in 1,3-PDO conversion between the strains. Therefore, as 199 expected, ALS inactivation decreased 2,3-BDO generation, although K. pneumoniae 200 ΔALS produced increased LAC (31.50 g L -1 ) than the parent strain (15.42 g L -1 ). This 201 suggests that ALS deletion shifted the carbon flux away from the biosynthesis of 202 2,3-BDO towards the production of LAC. The distribution of metabolites in fed-batch fermentations by K. pneumoniae ΔALS 227 and K. pneumoniae HSL4 ( Table 4 ) clearly showed that the flow of glycerol to 228 1,3-PDO and byproducts other than 2,3-BDO and ETH was increased in the mutant K. 229 pneumoniae ΔALS compared with the parent strain. It is worth noting that LAC 230 increased strikingly in K. pneumoniae ΔALS, and it was reported that 2,3-BDO 231 increased notably in a LAC-deficient mutant [12, 13] . In glycerol metabolism, LAC 232 and 2,3-BDO reside on separate branches downstream from pyruvate and both depend 233 on the action of dehydrogenase enzymes that use NADH as a cofactor. In general, one 234 pathway is likely to be strengthened when the other is blocked, therefore it is logical 235 that blocking 2,3-BDO biosynthesis resulted in the promotion of LAC biosynthesis in 236 this study. 
2,3-BDO stereoisomers in K. pneumoniae ΔALS and K. pneumoniae HSL4
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Klebsiella pneumoniae synthesizes both meso-2,3-BDO and 2S,3S-BDO through 240 fermentation of glycerol [17] . In this study, both mutant and the wild-type strains 241 were cultured with glycerol (30 g L -1 ) as the carbon source, and 1,3-PDO was the 242 main product with both strains (Fig. 5) . However, the strains produced different 243 amounts of 2,3-BDO of isomers; wild-type K. pneumoniae HSL4 produced 3.8 g L -1 244 meso-2,3-BDO and 0.20 g L -1 2S,3S-BDO after fermentation for 12 h, whereas K. 2,3-BDO, ETH, SUC and AC are among the major by-product metabolites generated, 254 and these can account for 40%-45% of the total metabolites. In this study, LAC 255 (15.42 g L -1 ) and 2,3-BDO (13.75 g L -1 ) were the two most abundant by-products and 256 reached 22.4% and 20.0% (w/w) that of 1,3-PDO (68.76 g L -1 ), which were the major 257 products in the fermentation broth of the wild-type strain. Minimizing the production 258 of by-products is an effective way to engineer the microbial strain to synthesize more 259 1,3-PDO. Both ETH [11] and LAC pathways of K. pneumoniae [13] and Klebsiella 13 260 oxytoca [12] have been successfully disrupted by knocking out genes encoding key 261 enzymes in these pathways. Inactivation of the ETH pathway by knocking-out ALDH 262 in K. pneumoniae YMU2 almost abolished ETH formation and significantly increased 263 1,3-PDO production [11] . Similarly, Yang et al. [12] reported that LAC-deficient 264 mutants of K. oxytoca were obtained by knocking out the gene encoding LDH. Their 265 results showed that 1,3-PDO concentration, productivity, and conversion rate can 266 enhanced above levels achieved by wild-type strains, and LAC production can be 267 diminished. However in their study, the distribution of metabolites were altered and 268 over 60 g L -1 2,3-BDO was produced as the major byproduct. Previously, the D-LAC 269 pathway of K. pneumoniae HR526 was disrupted by knocking out D-LAC 270 dehydrogenase [13] , which increased conversion of 1,3-PDO and 2,3-BDO from 0.55 271 mol mol -1 to 0.65 mol mol -1 , and the final LAC concentration decreased dramatically 272 from more than 40 g L -1 to less than 3 g L -1 . 273 To improve both the yield and productivity of 1,3-PDO from glycerol, disruption 274 of the 2,3-BDO pathway is an alternative strategy. In K. pneumoniae, the genes expression of formate dehydrogenase reduced 2,3-BDO production and increased 283 1,3-PDO production [24] , and disruption of the budC gene in K. pneumoniae ZG38 284 produced the same result [16] . Cui et al. [25] reported an improvement in the 285 intracellular redox state in 2,3-BDO-deficient mutants lacking budA and B. 286 Additionally, excess NADH was produced in the LAC-deficient mutant 287 overexpressing dhaT. Since the synthesis of 2,3-BDO is catalysed procedurally by 288 bud B, A and C and taking into account the reports that the mutation of budA and C 289 promoted 1,3-PDO production, it is deductive that budB disruption should also be 290 beneficial to the 1,3-PDO production. However, Oh et al. [26] reported the deletion of 291 ALS gene (budB), hampering efficient 1,3-PDO production. The logical prediction 292 was contradicted with the results by Oh et al. [26] . That implied the function of ALS 293 gene (budB) refering to glycerol metabolism was deserved to be further investigated. 294 In this study, an ALS-deficient strain was constructed using the Red 295 recombination system, and fermentation tests showed that inactivation of ALS caused 296 a redistribution of metabolic flux, resulting in a decrease in the synthesis of 2,3-BDO 297 and an increase in the synthesis of 1,3-PDO and LAC. Fermentation of K. 298 pneumoniae ΔALS using glycerol as a substrate resulted in the production of 72.04 g 299 L −1 of 1,3-PDO, which was a slightly higher than that of the parent strain (Table 3; 300 Fig. 4 ). Inactivation of the 2,3-BDO pathway was speculatively associated with a 301 decrease in the consumption of NADH under aerobic conditions (Fig. 1) . This 302 increases the available energy (NADH) supply that would otherwise be used by the 303 competing 2,3-BDO pathway under anaerobic conditions. Moreover, LAC was the 15 304 most abundant byproduct and reached 31.50 g L −1 , double that of the parent strain. 305 Cell growth was slightly decreased and glycerol utilization was slightly promoted 306 compared to the parent strain. Interestingly, synthesis of meso-2,3-BDO was markedly 307 inhibited in the mutant strain but synthesis of 2S,3S-BDO was increased (Fig. 5 ). This 308 indicates that an unknown enzyme catalyzes the conversion of pyruvate to diacetyl. 309 The mutant strain retained ~20% of the ALS activity of the parent strain, and this 310 unexpected residual activity may have contributed to the results. Firstly, this may 311 have complicated the enzyme assay which is based on measuring acetoin but not in 312 the presence of acetolactate. Secondly, there may exist unknown (iso)enzymes that are 313 functionally closely related to ALS, but this appears to be less likely. 314 Although the yield of 1,3-PDO was increased, the conversion was not promoted 315 to a great degree, mainly due to the accompanying increase in LAC synthesis. 316 Therefore, we predict that blocking LAC synthesis may be the preferred strategy 317 when engineering 1,3-PDO production in K. pneumoniae. Our results indicate that 318 2,3-BDO synthesis competes with the synthesis of 1,3-PDO and LAC. Moreover, 319 since blocking the formation of LAC stimulated 1,3-PDO and 2,3-BDO production in 320 Klebsiella species [12, 13] , we predict that knocking out ALS in combination with 321 engineering of the LAC pathway would result in a mutant with lower LAC and Table 1 Bacterial strains and plasmids Strain or plasmid Relevant genotype and description Source or reference
